D.H. Lim

A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial☆

S.H. Park, D.H. Lim, Tae Sung Sohn et al. · Annals of Oncology · 2020 · 272 citations · Full text

Diagnostic Dilemma of Pseudoprogression in the Treatment of Newly Diagnosed Glioblastomas: The Role of Assessing Relative Cerebral Blood Flow Volume and Oxygen-6-Methylguanine-DNA Methyltransferase Promoter Methylation Status

Doo‐Sik Kong, S.T. Kim, E.-H. Kim et al. · American Journal of Neuroradiology · 2011 · 192 citations · Full text

Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncologist's view

D.H. Lim, D Y Kim, Minyong Kang et al. · British Journal of Cancer · 2004 · 78 citations · Full text

Surgical Oncology, Gastroenterology, Adjuvant Chemotherapy +18

Tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma: Results of SMC NB-2004 study

Ki Woong Sung, Meong Hi Son, Sun‐Ho Lee et al. · Bone Marrow Transplantation · 2012 · 56 citations

Cell Therapy, Transplantation, Oncology +10

Reduced-dose craniospinal radiotherapy followed by tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk medulloblastoma

Ki Woong Sung, D.H. Lim, Miseol Son et al. · Neuro-Oncology · 2012 · 38 citations · Full text